Karine Charton

644 total citations
19 papers, 485 citations indexed

About

Karine Charton is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Karine Charton has authored 19 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cell Biology. Recurrent topics in Karine Charton's work include Muscle Physiology and Disorders (16 papers), Calpain Protease Function and Regulation (6 papers) and Cardiomyopathy and Myosin Studies (6 papers). Karine Charton is often cited by papers focused on Muscle Physiology and Disorders (16 papers), Calpain Protease Function and Regulation (6 papers) and Cardiomyopathy and Myosin Studies (6 papers). Karine Charton collaborates with scholars based in France, Finland and United States. Karine Charton's co-authors include Isabelle Richard, Carinne Roudaut, Anna Vihola, Laurence Suel, Nathalie Bourg, Florence Le Roy, J. Sarparanta, Jérôme Poupiot, William Lostal and Evelyne Gicquel and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Cell Biology.

In The Last Decade

Karine Charton

19 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karine Charton France 15 436 175 90 85 83 19 485
Nathalie Deburgrave France 13 461 1.1× 109 0.6× 91 1.0× 91 1.1× 149 1.8× 26 567
Burcu Balcı-Hayta Türkiye 10 383 0.9× 70 0.4× 140 1.6× 50 0.6× 75 0.9× 19 489
Hülya Gündeşli Türkiye 7 343 0.8× 76 0.4× 124 1.4× 38 0.4× 75 0.9× 12 417
Francesco Muntoni United Kingdom 5 1.1k 2.6× 216 1.2× 171 1.9× 71 0.8× 85 1.0× 8 1.2k
Ludovic Arandel France 9 351 0.8× 69 0.4× 49 0.5× 96 1.1× 70 0.8× 11 393
J. van Reeuwijk Netherlands 5 399 0.9× 45 0.3× 77 0.9× 72 0.8× 83 1.0× 6 446
Michela Salamon Italy 9 466 1.1× 382 2.2× 94 1.0× 65 0.8× 126 1.5× 10 639
Steve Laval United Kingdom 11 401 0.9× 91 0.5× 92 1.0× 34 0.4× 56 0.7× 12 432
William Lostal France 10 442 1.0× 92 0.5× 43 0.5× 154 1.8× 48 0.6× 15 466
Ivana Prokic France 7 296 0.7× 95 0.5× 231 2.6× 42 0.5× 109 1.3× 7 432

Countries citing papers authored by Karine Charton

Since Specialization
Citations

This map shows the geographic impact of Karine Charton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Charton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Charton more than expected).

Fields of papers citing papers by Karine Charton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Charton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Charton. The network helps show where Karine Charton may publish in the future.

Co-authorship network of co-authors of Karine Charton

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Charton. A scholar is included among the top collaborators of Karine Charton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Charton. Karine Charton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bourg, Nathalie, Jérôme Poupiot, Karine Charton, et al.. (2022). Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy. Life Science Alliance. 6(1). e202201506–e202201506. 9 indexed citations
2.
Chandra, Goutam, Sen Chandra Sreetama, Davi A. G. Mázala, et al.. (2021). Endoplasmic reticulum maintains ion homeostasis required for plasma membrane repair. The Journal of Cell Biology. 220(5). 17 indexed citations
3.
Sreetama, Sen Chandra, Karine Charton, Marshall W. Hogarth, et al.. (2021). Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits. Journal of Neuromuscular Diseases. 8(s2). S243–S255. 7 indexed citations
4.
Lostal, William, Carinne Roudaut, Karine Charton, et al.. (2019). Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A. Science Translational Medicine. 11(520). 22 indexed citations
5.
Gicquel, Evelyne, William Martin, Nathalie Bourg, et al.. (2017). AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression. Human Molecular Genetics. 26(10). 1952–1965. 35 indexed citations
6.
Vihola, Anna, H. Luque, Marco Savarese, et al.. (2017). Diagnostic anoctamin‐5 protein defect in patients with ANO5‐mutated muscular dystrophy. Neuropathology and Applied Neurobiology. 44(5). 441–448. 16 indexed citations
7.
Charton, Karine, et al.. (2016). Exploiting the CRISPR/Cas9 system to study alternative splicingin vivo: application to titin. Human Molecular Genetics. 25(20). ddw280–ddw280. 19 indexed citations
8.
Israeli, David, Jérôme Poupiot, Fatima Amor, et al.. (2016). Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies. Scientific Reports. 6(1). 28097–28097. 33 indexed citations
9.
Lostal, William, Nathalie Bourg, Karine Charton, et al.. (2015). A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequence. Molecular Therapy — Methods & Clinical Development. 2. 15009–15009. 36 indexed citations
10.
Charton, Karine, J. Sarparanta, Anna Vihola, et al.. (2015). CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy. Human Molecular Genetics. 24(13). 3718–3731. 36 indexed citations
11.
Cid, Rafael de, Rabah Ben Yaou, Carinne Roudaut, et al.. (2015). Exome sequencing identifies novel truncating TTN mutations with Emery–Dreifuss like muscular dystrophy and secondary calpain3 deficiency without cardiac abnormality. Neuromuscular Disorders. 25. S245–S245. 1 indexed citations
12.
Cid, Rafael de, Rabah Ben Yaou, Carinne Roudaut, et al.. (2015). A new titinopathy. Neurology. 85(24). 2126–2135. 36 indexed citations
13.
Bourg, Nathalie, Laurence Suel, Carinne Roudaut, et al.. (2014). Cis -splicing and Translation of the Pre- Trans -splicing Molecule Combine With Efficiency in Spliceosome-mediated RNA Trans -splicing. Molecular Therapy. 22(6). 1176–1187. 26 indexed citations
14.
15.
Blandin, Gaëlle, Sylvie Marchand, Karine Charton, et al.. (2013). A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome. Skeletal Muscle. 3(1). 3–3. 36 indexed citations
16.
Roudaut, Carinne, Florence Le Roy, Laurence Suel, et al.. (2013). Restriction of Calpain3 Expression to the Skeletal Muscle Prevents Cardiac Toxicity and Corrects Pathology in a Murine Model of Limb-Girdle Muscular Dystrophy. Circulation. 128(10). 1094–1104. 39 indexed citations
17.
Charton, Karine, Nathalie Danièle, Anna Vihola, et al.. (2010). Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies. Human Molecular Genetics. 19(23). 4608–4624. 30 indexed citations
18.
Sarparanta, J., Gaëlle Blandin, Karine Charton, et al.. (2010). Interactions with M-band Titin and Calpain 3 Link Myospryn (CMYA5) to Tibial and Limb-girdle Muscular Dystrophies. Journal of Biological Chemistry. 285(39). 30304–30315. 55 indexed citations
19.
Roy, Florence Le, Karine Charton, Christian L. Lorson, & Isabelle Richard. (2009). RNA-targeting approaches for neuromuscular diseases. Trends in Molecular Medicine. 15(12). 580–591. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Deburgrave Breakdown of academic impact, for papers by Burcu Balcı-Hayta Breakdown of academic impact, for papers by Hülya Gündeşli Breakdown of academic impact, for papers by Francesco Muntoni Breakdown of academic impact, for papers by Ludovic Arandel Breakdown of academic impact, for papers by J. van Reeuwijk Breakdown of academic impact, for papers by Michela Salamon Breakdown of academic impact, for papers by Steve Laval Breakdown of academic impact, for papers by William Lostal Breakdown of academic impact, for papers by Ivana Prokic
Rankless by CCL
2026